![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Tolerability and antiviral activity of bictegravir/tenofovir
alafenamide/emtricitabine (Biktarvy) treatment switch
in patients aged 55 years or older with HIV: the BIO study
|
|
|
EACS 2021 Oct 27-30
R. Finlayson1, J. Carson2, L. Tan1
1Taylor Square Private Clinic, Clinical Research, Sydney, Australia, 2University of New South Wales, The Kirby Institute, Sydney, Australia
![1106211](../images/110521/110621-9/1106211.gif)
![1106212](../images/110521/110621-9/1106212.gif)
![1106213](../images/110521/110621-9/1106213.gif)
![1106214](../images/110521/110621-9/1106214.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|